Literature DB >> 2819074

Liposome fusion catalytically induced by phospholipase C.

J L Nieva1, F M Goñi, A Alonso.   

Abstract

Large unilamellar vesicles composed of phosphatidylcholine/phosphatidylethanolamine/cholesterol (50:25:25 mole ratio) were treated with phospholipase C. The early stages of phospholipid cleavage are accompanied by mixing of bilayer lipids (monitored by dequenching of octadecylrhodamine fluorescence) and leakage-free mixing of vesicle contents [measured by using 8-aminonaphthalene-1,3,6-trisulfonic acid (ANTS) and p-xylylenebis(pyridinium bromide) (DPX)]. These results are interpreted in terms of vesicle fusion induced by the catalytic activity of phospholipase C. The use of sonicated unilamellar vesicles decreases the lag time, but does not modify the amplitude, of the fusion process. The presence of both phosphatidylethanolamine and cholesterol appears to be essential for measurable fusion effects to occur with low levels of phospholipid hydrolysis. Optimal fusion rates are observed with about 10-20 enzyme molecules per large unilamellar vesicle. This system of catalytically induced liposome fusion may be of relevance for the interpretation of physiological membrane fusion processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2819074     DOI: 10.1021/bi00444a032

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

Review 1.  Membrane fusion.

Authors:  K N Burger; A J Verkleij
Journal:  Experientia       Date:  1990-06-15

2.  Diacylglycerol and the promotion of lamellar-hexagonal and lamellar-isotropic phase transitions in lipids: implications for membrane fusion.

Authors:  G Basanez; J L Nieva; E Rivas; A Alonso; F M Goni
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

3.  Interaction of cholesterol-crystallization-promoting proteins with vesicles.

Authors:  M A de Bruijn; B G Goldhoorn; A I Zijlstra; G N Tytgat; A K Groen
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

4.  Morphological changes induced by phospholipase C and by sphingomyelinase on large unilamellar vesicles: a cryo-transmission electron microscopy study of liposome fusion.

Authors:  G Basáñez; M B Ruiz-Argüello; A Alonso; F M Goñi; G Karlsson; K Edwards
Journal:  Biophys J       Date:  1997-06       Impact factor: 4.033

5.  End-product diacylglycerol enhances the activity of PI-PLC through changes in membrane domain structure.

Authors:  Hasna Ahyayauch; Jesús Sot; M Isabel Collado; Nerea Huarte; José Requejo-Isidro; Alicia Alonso; Félix M Goñi
Journal:  Biophys J       Date:  2015-04-07       Impact factor: 4.033

6.  Modeling degranulation with liposomes: effect of lipid composition on membrane fusion.

Authors:  T G Brock; K Nagaprakash; D I Margolis; J E Smolen
Journal:  J Membr Biol       Date:  1994-08       Impact factor: 1.843

7.  Ceramide-enriched membrane domains in red blood cells and the mechanism of sphingomyelinase-induced hot-cold hemolysis.

Authors:  L-Ruth Montes; David J López; Jesús Sot; Luis A Bagatolli; Martin J Stonehouse; Michael L Vasil; Bill X Wu; Yusuf A Hannun; Félix M Goñi; Alicia Alonso
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

8.  Sphingosine increases the permeability of model and cell membranes.

Authors:  F-Xabier Contreras; Jesús Sot; Alicia Alonso; Félix M Goñi
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

9.  Diacylglycerol-rich domain formation in giant stearoyl-oleoyl phosphatidylcholine vesicles driven by phospholipase C activity.

Authors:  Karin A Riske; Hans-Günther Döbereiner
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

10.  End-products diacylglycerol and ceramide modulate membrane fusion induced by a phospholipase C/sphingomyelinase from Pseudomonas aeruginosa.

Authors:  Maitane Ibarguren; Paul H H Bomans; Peter M Frederik; Martin Stonehouse; Adriana I Vasil; Michael L Vasil; Alicia Alonso; Félix M Goñi
Journal:  Biochim Biophys Acta       Date:  2009-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.